Foldink® is a Biotechnology startup which provides 3D Bioprinting technology to biomedical scientists who are conducting research in tissue engineering and regenerative medicine.
Foldink’s 3D Bioprinters and Bioinks help scientist to develop living tissue constructs. Biofabricated tissues can be used in scientific experiments, pharmacological research, development of cosmetics and pharmaceutical products. The aim of this field of science is to achieve the clinical application of 3D printed organs and tissues. This process has started, and 3D bioprinting is moving from theoretical science into the use in hospitals as an alternative to transplantation. The usage of bioprinted organs in the future will solve the worldwide lack of organ-transplants, which leads to the death of many patients even in highly developed countries. Unfortunately, the development of 3D bioprinting technology is hampered by the fact that it is not yet available for many scientists in the world. Foldink is going to change this, by making 3D bioprinting technology available for every laboratory.
Foldink is developing 3D bioprinters with microextrusion Syringe-Based System and bioinks to create cell-laden tissue scaffolds.
We believe that Foldink bioprinters will be a catalyst for the development of tissue engineering and regenerative medicine.
So, let’s Print the Future Together!
-
Industry
-
Biotechnology Research
-
Company size
-
2-10 employees
-
Headquarters
-
Frisco, Texas
-
Type
-
Privately Held
-
Founded
-
2018
-
Specialties
-
Bioprinting, Research and development, biotechnology, Biomedicine, medical technologies, regenerative Medicine, Innovative technnologies, 3d printing, tissue engineering, healtchare, medicaldevice, and bioengineering
